18F-LY-3546117

N/A

Report date: 2025/12/01 17:16:51

Base Information

Drug Name18F-LY-3546117

Drug Alias Name18F-LY-354611718F-LY3546117

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionRadionuclide imaging enhancersPositron-emission tomography enhancersGranzyme B binders

TargetsGranzyme B

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAvid Radiopharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvid Radiopharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A